Evotec SE American Depositary Shares (EVO) is a publicly traded Healthcare sector company. As of May 21, 2026, EVO trades at $2.90 with a market cap of $973.22M and a P/E ratio of 0.00. EVO moved +2.70% today. Year to date, EVO is -10.97%; over the trailing twelve months it is -30.22%. Its 52-week range spans $2.31 to $5.64. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces EVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Evotec SE American Depositary Shares (EVO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. EVO moved +2.70% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.90 |
| Market Cap | $973.22M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.07% |
| 52-Week High | $5.64 |
| 52-Week Low | $2.31 |
| Volume | 33.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover EVO: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.